• News
  • SAN DIEGO
  • BioTech

ViaCyte raises $5.4M for diabetes treatment

San Diego-based ViaCyte Inc. has completed a private equity financing transaction, providing the company with $5.4 million through the sale of Series C-1 Preferred Stock.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!